Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Naked Brand Group Actually Has a Shot at a Turnaround

By Mark R. Hake, CFA

Naked Brand Group might actually turnaround. Investing in NAKD stock has a minimum expected return of a 20% gain using probability analysis.

Why Jumia Technologies Could Move Much Higher

By Mark R. Hake, CFA

Jumia Technologies has had an amazing turnaround and could move much higher. If Citron Research is to be believed, JMIA stock could be another AMZN stock, worth over $100 per share.

Lemonade Stock Is Set for a Huge Fall Even If This Short-Seller Is Wrong

By Mark R. Hake, CFA

Lemonade Insurance stock could be set for a huge fall. LMND stock is 65% overvalued and is set for a fall, according to the short-seller The Friendly Bear.

Bitcoin Is Becoming Accepted as a Long-Term Institutional Investment

By Mark R. Hake, CFA

Bitcoin is becoming accepted as a long-term institutional investment. Bitcoin is expected to rise by over 36% annually over the next five years.

Tuscan Holdings Could See 50% Gains After Closing This EV SPAC Merger

By Mark R. Hake, CFA

Tuscan Holdings will likely be worth 50% more when it closes its EV SPAC merger. THCB stock is worth between $24.62 and $28.46, or 44% to 66% more than $17.10, its price on Dec. 31.

Load More